To report the case of a patient, who in the context of an anti-Parkinsonian therapy, developed addiction to apomorphine. Methods Clinical case description. Results Apomorphine is a dopaminergic agonist that acts directly on D2 receptors. It has been used in alcoholism, male sexual dysfunction and with diagnostic and therapeutic purposes in Parkinson's disease (PD). Conclusions The present work describes the case of a woman with PD who developed a loss of control over the consumption of apomorphine that resulted in a significant impairment of her functioning. PD patients with high frequency develop different psychiatric symptoms. Conversely, anti-Parkinsonian drugs also generate psychiatric symptoms that can be experienced by the patient as ...
In a small number of patients with Parkinson’s disease (PD), a series of behavioral disorders includ...
Background: Visual hallucinations (VH) occur in the clinical course of Parkinson's disease (PD) and ...
Abstract Background Current evidence linking the development of Parkinson’s disease after the use of...
To report the case of a patient, who in the context of an anti-Parkinsonian therapy, developed addic...
International audienceApomorphine is now recognized as the oldest antiparkinsonian drug on the marke...
Penile erections were regularly induced by intermittent subcutaneous injections of apomorphine in fi...
International audienceObjective: To investigate the potential role of apomorphine as a treatment for...
Around 1 in 7 people with Parkinson's disease develop addictive behaviours from their daily medicati...
Apomorphine is a potent, nonselective, direct-acting dopamine-receptor agonist. Given subcutaneously...
The compulsive use of dopamine replacement therapy (DRT) or dopamine dysregulation syndrome (DDS) is...
Visual hallucinations (VHs) often occur in patients with advanced Parkinson disease (PD). Overstimul...
Levodopa-induced motor fluctuations (MF) is a disabling complication of Parkinson's disease (PD) and...
Apomorphine induces behavioural changes in man in some way similar to those elicited by low doses of...
Abstract Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compuls...
Visual hallucinations (VHs) often occur in patients with advanced Parkinson disease (PD). Overstimul...
In a small number of patients with Parkinson’s disease (PD), a series of behavioral disorders includ...
Background: Visual hallucinations (VH) occur in the clinical course of Parkinson's disease (PD) and ...
Abstract Background Current evidence linking the development of Parkinson’s disease after the use of...
To report the case of a patient, who in the context of an anti-Parkinsonian therapy, developed addic...
International audienceApomorphine is now recognized as the oldest antiparkinsonian drug on the marke...
Penile erections were regularly induced by intermittent subcutaneous injections of apomorphine in fi...
International audienceObjective: To investigate the potential role of apomorphine as a treatment for...
Around 1 in 7 people with Parkinson's disease develop addictive behaviours from their daily medicati...
Apomorphine is a potent, nonselective, direct-acting dopamine-receptor agonist. Given subcutaneously...
The compulsive use of dopamine replacement therapy (DRT) or dopamine dysregulation syndrome (DDS) is...
Visual hallucinations (VHs) often occur in patients with advanced Parkinson disease (PD). Overstimul...
Levodopa-induced motor fluctuations (MF) is a disabling complication of Parkinson's disease (PD) and...
Apomorphine induces behavioural changes in man in some way similar to those elicited by low doses of...
Abstract Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compuls...
Visual hallucinations (VHs) often occur in patients with advanced Parkinson disease (PD). Overstimul...
In a small number of patients with Parkinson’s disease (PD), a series of behavioral disorders includ...
Background: Visual hallucinations (VH) occur in the clinical course of Parkinson's disease (PD) and ...
Abstract Background Current evidence linking the development of Parkinson’s disease after the use of...